Project leader

Dr. Iris Stallkamp
Phone:+49 641 943 6433
Fax:+49 641 943 6499

Project staff

Mr. Michael Haberland
Phone:+49 641 943 6450
Fax:+49 641 943 6499

Institute presentation

TransMIT GmbH is a technology transfer organisation highly experienced in evaluation and protection of intellectual property including all issues of patents and IP. On the road to a new product or the market, the core offer furthermore comprises the realisation of innovation plans or a growth target. In the framework of such projects, TransMIT realises, for its clients, via its business unit “Patents and Innovation Consultation” a technological or economic evaluation, compiles business plans, or searches for licence partners and co-investors. TransMIT administers more than 1,200 property rights and negotiates more than 400 contracts with the industry per year.

Moreover, TransMIT assists development projects on several levels. The company provides experience in the planning of the preclinical development of new active agents and diagnostics and performs project management including search and coordination of development partners, communication and dissemination of work package results, and logistics e.g. for material synthesized according to GMP standards.

In the context of its business unit “TransMIT Centres and Project Divisions”, the company provides services related to CE certification. Within this business unit, scientists from universities offer their products, services, and knowhow within a professional framework to the industry. In this sense, “TransMIT Centres and Project Divisions” perform, under the supervision of reputable experts, their task as catalyst, link and consultation provider at the interface between science and commerce. As such, TransMIT represents the “Project Division for Molecular Nuclear Imaging”, which is engaged in the development of new radiolabelled peptides for scintigraphic diagnosis of diabetes and localisation of pancreas tumours like insulinoma and small-scale carcinomas.

TransMIT Gesellschaft für Technologietransfer mbH, Giessen/Germany (TRM), will contribute to WP3 and 6. The main tasks within the project will be patent and IP issues, support for CE certification, coordination of GMP production, delivery, and toxicity testing of tracer and dissemination of project results

Print
Top